Major League Baseball pitcher José Urquidy is now a free agent after the Detroit Tigers declined his $4 million option for the 2026 season. This decision comes after Urquidy spent significant time recovering from major elbow surgery.
Urquidy underwent Tommy John surgery, a procedure that repairs the ulnar collateral ligament in the elbow. Recovery from this surgery typically takes 12 to 18 months of rigorous rehabilitation, which caused him to miss most of the last two seasons.
Despite the setback, his rehab appearances showed encouraging signs. In 21.2 innings across various minor league levels, he posted a 2.91 ERA and maintained an 18-to-5 strikeout-to-walk ratio, demonstrating his command was returning.
According to Reuters, the Tigers’ choice to decline the option provides them with financial flexibility and allows Urquidy to seek a new team for the upcoming season.
The move allows the Tigers financial flexibility. It also gives Urquidy the chance to find a new team for the upcoming season.
Now on the free agent market, Urquidy offers seasoned, cost-effective pitching depth. His proven track record before the injury makes him an appealing option for teams needing experienced starters.
Before his surgery, Urquidy was a reliable starter.
His recent performances suggest he can still be an effective pitcher when fully healthy.
Author's summary: José Urquidy enters free agency after the Tigers declined his 2026 option, presenting an opportunity for teams seeking experienced pitching depth following his recovery from Tommy John surgery.